Cargando…
Current Status of Dapagliflozin in Congestive Heart Failure
Heart failure is a prominent clinical condition and a top concern as a widespread health issue. The incidence of heart failure is rising alarmingly on a global scale. Heart failure significantly strains the whole healthcare system financially, degrading the patient's quality of life and increas...
Autores principales: | Palandurkar, Gopal, Kumar, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586194/ https://www.ncbi.nlm.nih.gov/pubmed/36304362 http://dx.doi.org/10.7759/cureus.29413 |
Ejemplares similares
-
Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure
por: MIZUNO, Masashi, et al.
Publicado: (2016) -
Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic
peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015) -
Congestive Heart Failure: A History
por: Hajar, Rachel
Publicado: (2019) -
Sotagliflozin vs Dapagliflozin: A Systematic Review Comparing Cardiovascular Mortality
por: Iyer, Nandhini, et al.
Publicado: (2023) -
Edema formation in congestive heart failure and the underlying mechanisms
por: Abassi, Zaid, et al.
Publicado: (2022)